Novartis Korea Limited is an enterprise located in South Korea, with the main office in Seoul. It operates in the Pharmaceutical and Medicine Manufacturing industry. Novartis Korea Limited was incorporated on September 20, 1984. It currently has a total number of 466 (2026) employees. From the latest financial highlights, Novartis Korea Limited reported a net sales revenue increase of 4.56% in 2024. Its total assets decreased by 10.94% over the same period. Novartis Korea Limited’s net profit margin decreased by 0.54% in 2024.

Headquarters
Gukjegeumyung-ro Yeongdeungpo-gu Seoul
Seoul; Seoul;

Contact Details: Purchase the Novartis Korea Limited report to view the information.

Website: http://www.novartis.co.kr

Basic Information

Total Employees:

Purchase the Novartis Korea Limited report to view the information.

Outstanding Shares:

Purchase the Novartis Korea Limited report to view the information.

Registered Capital:

Purchase the Novartis Korea Limited report to view the information.

Financial Auditors:

Purchase the Novartis Korea Limited report to view the information.

Incorporation Date:

September 20, 1984

Key Executives

Purchase this report to view the information.

Chairman

Ownership Details

Purchase this report to view the information.

78.6%

Purchase this report to view the information.

21.4%

Subsidiaries

Sandoz Korea Ltd.

Company Performance

Financial values in the chart are available after Novartis Korea Limited report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.

Net sales revenue

4.56%▲

Total Operating Revenue

4.56%▲

Operating Profit

-14.72%▼

EBITDA

-14.65%▼

Net Profit/Loss for the Period

-8.25%▼

Total Assets

-10.94%▼

Total Equity

1.67%▲

Operating Profit Margin

-0.84%▼

Net Profit Margin

-0.54%▼

Return on Equity (ROE)

-2.02%▼

Debt / Equity

3.57%▲

Quick Ratio

0.15%▲

Novartis Korea Limited (South Korea)

Similar companies